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Nitratedpolycyclicaromatichydrocarbons (nitro-PAHs) areformedduringincomplete combustion.Sources
include emissions from vehicles (mainly diesel vehicles), heating, smoking, certain types offood processing,
and incomplete combustion in general. Nitro-PAHs are direct-acting mutagens, and a number ofthem have
been shown to be carcinogens. 2-Nitrofluorene (NF) represents a model substance for the nitro-PAHs. An
attempt has been made to calculate the human cancer risk due to exposure to nitro-PAHs by two different
models. Inthefirstmodel,genotoxiclesionsweretransferredtounitsofGray(y-irradiation), andinthesecond
model amega study (24,000 animals) onthecarcinogenicity ofone metabolite ofNF was usedtoelucidate the
risk.Gamma-irradiation oftheratlivergaverisetopreneoplastic foci inadose-dependent manner.whichwas
statistically significant. The Gray-equivalents ofchemically (NF) induced foci were calculated, and from the
human nitro-PAH exposure, expressed inSievert, a human riskestimate wascalculated. In the second model,
an extrapolation from laboratory animals to man was performed because tumor data on 2-acety-
laminofluorene (AAF), a major metabolite of NF, were available in the literature. The tumor dose-response
dataonAAFwaslinearfortestedlifetime doses.Theresultsofbothmodelsagreed,withariskrangeof0.15-49
x 10-i on human cancer risk for an urban citizen.
Introduction
Incomplete combustion is a major problem in terms of
pollution. Examples include emissions from energy pro-
duction, industrial processes, vehicles, and smoking. The
biological effects ofincomplete combustion can be divided
into effects on human health or on the ecosystem. Both
effects can be acute or long term. The different biological
responses can be related to each other because the same
substance in the emissions can give rise to several reac-
tions in the organism orthe ecosystem. One such example
is the group ofnitrated polycyclic aromatic hydrocarbons
(nitro-PAHs). Fortheformationofnitro-PAHs,incomplete
combusted organic material (PAH) and oxidized nitrogen
(NO,) are necessary. A low pH (SO2, NOx) catalyzes the
reaction. NOX is one important combustion product
responsible for acidification of the environment, acute
health effects (1), as well as formation of nitro-PAHs (2),
which are stronggenotoxic agents in mammalian systems
(3-7). Becausetheformation ofnitro-PAHs is catalyzedby
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a low pH, the reaction product, NOR, catalyzes its own
reaction with PAHs in the formation ofnitro-PAHs.
Nitro-PAHs are found in emissions from diesel- (8) and
gasoline-powered (9) vehicles, in the exhaust from kero-
sene heaters (10), in urban air (11-14), in river sediments
(15), and in certain food products (16,17). Nitro-PAHs can
beformedduringcombustion oras aresultofphotochemi-
calreactions ofPAHs (18) oramino-PAHs (19). Nitro-PAH
formation has also been reported to occur in the water
phase with nitrite as a donor ofthe nitro group (20,21).
Nitro-PAHs are a group of at least 200 different sub-
stances. Manyofthemaremutagens(22-25),andthemost
potent bacterial mutagens known today, the dinitropy-
renes, are found in this group (26). Anumber ofthe nitro-
PAHs are also carcinogenic in laboratory animals (27,28).
2-Nitrofluorene (NF) is one ofthe more common nitro-
PAHs, found in the environment (29-33) with 1-nitro-
pyrene (NP). NF has been suggested to be a model sub-
stance for nitro-PAHs in the gas and particle phase,
whereas NPisregarded tobe amodel substance fornitro-
PAHs in the particle phase (34).
NF is a mutagen (25) as well as a carcinogen (28) in
laboratory animals. NF was elucidated bythe International
Agencyfor Research on Cancer (IARC), and the conclusion
wasthatthereis"sufficientevidence"forthecarcinogenicity
in experimental animals. Concerning the evaluation for
human health the statement was that NF is a "possible
carcinogentohumans"(35).Theevaluationfordieselexhaust
was that it is "probably carcinogenic" to humans (35).MOLLER ET AL.
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FIGURE 1. The chemical structure of2-nitrofluorene.
NF has been studied in detail in ourlaboratoryfrom an
analytical point ofview (36), and with regard to metabo-
lism(37-39),lungeffects (40,41), andgenotoxiceffects (42-
44). AreviewofNF's prevalence and biological effects has
also been published (45). The chemical structure ofNF is
shown in Figure 1.
Results and Discussion
Forthe groupofnitro-PAHs, epidemiology orstudies on
specially selected groups are more or less impossible to
perform because nitro-PAHs constitute only part of the
products ofincomplete combustion. Itis extremelyhard to
define a groupofpeoplethatis exposed to nitro-PAHs and
a control group that is exactly the same from all aspects
except that it is not exposed to nitro-PAHs. Nitro-PAHs
always occur with other carcinogens (combustion prod-
ucts), and therefore another approach must be used to
elucidate the genotoxic risk.
2-Nitrofluorene, a Potent Genotoxic Model
Compound for Nitro-PAHs
2-Nitrofluorene (NF) and1-nitropyrene (NP) havebeen
selected as model compounds forthe group ofnitro-PAHs.
The basic structures, fluorene and pyrene, are common in
emissions from incomplete combustion. Because nitrogen
oxides are also present during combustion, the reaction
products NF and NP are common in environmental analy-
ses (8-17). NP occurs in theparticle phase,whereas NF is
found with a 50/50 distribution in the particle and semi-
volatile phase (34).
In ourstudies, NF was selected asthemodelcompound.
NF is a direct-acting mutagen in bacterial test systems
and is often used as apositive control in genotoxic assays.
In Table 1, a summary of some ofthe existing data on the
genotoxicity of NF is shown.
Table 1. A summary ofthe biological effects of2-nitrofluorene.
Assay Effecta Reference
Sister chromatid exchange + (3,5)
Initiator + (44)
Promoter + (44)
Carcinogenicity + (27,56)
Formation ofDNA adducts + (69)
Micronuclei assays - (6,70-72)
Bacterial mutagenicity (Salmonella) + (74-76)
Bacterial mutagenicity (E. coli) + (77)
Mutagenicity, mouse lymphoma assay + (3,73,78)
a(+) Positive effect; (-) no effect.
Metabolism of2-Nitrofluorene
Although NF is achemicallystablemolecule, itis exten-
sivelymetabolizedinthe organism. Afteroral administra-
tionofNF,themajorpartofthe doseisexcretedwithin48
hr (37,39). After 4 hr, approximately 2% of the dose has
been metabolized by the intestinal microflora, absorbed,
and metabolized (several steps) in the liver, distributed in
the circulation, filtered by the kidneys, and excreted in
urine. The excretion of metabolites is accompanied by
excretion of mutagenicity. Typically, direct-acting muta-
genicity (-S9) dominates over mutagenicity in the pres-
cence ofS9, both in urine and feces (37,39).
The in vivo formation (37) of the potent carcinogen
2-acetylaminofluorene [AAF (46)] is indicated. After an
oral dose ofNF to rats, NF is reduced to 2-aminofluorene
(AF) by the intestinal microflora, acetylated to AAF, and
further hydroxylated in the liver, resulting in OH-AAF
compounds,whichcanbeexcreted assuchorinconjugated
form. This metabolic route is quantitatively the most
important. AAF has been a model compound for chemical
carcinogenesis since the Wilson's early finding ofits car-
cinogenic potential in 1941 (47). AAF has been used in a
number of bioassays and has been characterized from
manydifferentpoints ofview(48). AAF is notfound inthe
environment, and occupational exposure can only occur
when AAF is used in research. It is thus ofconcernwhen
anenvironmentalpollutant(NF) commonlyfoundindiesel
exhaust (9,49-51) has the capacity to be metabolized to
this potent carcinogen in vivo. Other nitro-PAHs have
been shown to form acetylated metabolites, although the
biological significance of these metabolites is not known
(52,53).
After oral administration of NF, an alternative meta-
bolic route results in the formation of OH-NFs. This is
seen after induction of the cytochrome P450 system in
vivo. It is also seen in isolated, perfused lung and liver as
well as in germ-free animals (37-39). OH-AAFs are con-
sidered to be detoxification products (54) and have a low
mutagenic potency (55). OH-NFs, on the other hand, are
more mutagenic than NF itself (39). So far, nothing is
known about the carcinogenic potential ofOH-NFs, butit
cannot be excluded that they are carcinogenic. They may,
forexample, beinvolvedinthe tumorformation seen inthe
forestomach after oral dosing of NF. No forestomach
tumors are seen after administration ofAF or AAF. OH-
NFs mayalsoplayarolein theformation ofsubcutaneous
tumors after skin application of NF (28,56). The metabo-
lism ofNF is shown in Figure 2.
Are Animal Data Relevant to Humans?
One can always argue whether data on animal metabo-
lism arerelevanttohumans,butinthe caseofnitro-PAHs,
there are a number of factors indicating that animal
studies are relevant to the human situation: a) Reduction
ofnitro-PAHs to amino-PAHs canbeperformedbyanaer-
obic fecal bacterial suspensions from humans as well as
from rats (57-59). b) Human liver S9 bioactivates AF and
AAF to mutagens (60). c) Human hepatoma cell lines can
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FIGURE 2. The pathways for the metabolism of2-nitrofluorene.
perform nitroreduction as well as ring hydroxylation of
NP (61). d) Livermicrosomalmetabolism ofAAFis similar
in rats and humans (62). e) Human lymphocytes metabo-
lize AAF to ring- and N-OH derivatives of AAF (63).J)
AAF metabolism is similar in cultures of epithelial cells
fromhuman andratbladder (64).g) Ithasbeenshownthat
the carcinogen AAF given orally to humans results in the
same urinary metabolites as in the rat (65).
Risk Calculations Using AAF
In the AAF model, combined data have been used from
the metabolic pathways (NF metabolized to AAF in vivo)
and a mega-study (66) performed on 24,000 animals to
elucidate the carcinogenic potential ofAAF at lowlifetime
dosing. The tumor data on the liver have been used forthe
extrapolation to man. The dose-response curve for tumor
formation in the animal study after lifetime dosing was
linear. In the calculations (67), the animal data have been
extrapolated to man. The positive and negative comments
thatcouldbemaderegardingthismodel arefoundinTable
2. With an estimated human lifetime dose range for an
urban citizen, as discussed byMolleretal. (73), the human
cancer risk is p(x) = 1.1 - 49 x 10-6. Weaknesses and
strengths ofthe AAF model are discussed in Table 2.
ITable 2. Weaknesses and strengths ofthe
2-acetylaminofluorene (AAF) model.
Weaknesses
Data extrapolated from animals to man.
Apartofthe human dose of2-nitrofluorene (NF) mightundergoring-
hydroxylation instead ofreduction and acetylation. However; much
more potent mutagens (carcinogens?) are formed via that route.
Strengths
Many animals in the cancer study (24,000).
Known metabolism for the model compound (NF).
Low lifetime doses ofAAF gives rise to tumors.
The dose-response curve was linear for liver tumors on which the
calculations were performed.
The metabolism in laboratory animals and man is probably similar.
The AAF model is an in vivo model.
AAF is considered a human carcinogen.
Enzymes necessary for the metabolic pathways are found in man.
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Risk Calculations Using y-Radiation
Eqivalents
The y-model is totally different from the AAF model in
that known human risk data on y-irradiation is the basis
for the risk calculation. The genotoxic effects in the rat
liver after exposure to NF occur as preneoplastic lesions
(44). The same genotoxic lesions can be formed after
exposure to -y-irradiation ofthe ratlivers (67). The dose of
y-irradiation was exact in terms ofdose maxima, exposed
area, standard deviation of the dose, etc., because
y-irradiation apparatus for human cancer treatment was
used (67). In this way the genotoxic lesions caused by NF
could be converted to y-irradiation equivalents (Gy). The
totalhumandoseofnitro-PAHscouldthenbeexpressedin
radiation units, which made it possible to use human risk
data on carcinogenesis after y-irradiation exposure to
largepopulations (68).Withthesameestimatedlifedoseof
nitro-PAHs as used in the AAF model, the human cancer
risk for an urban citizen is p(x) = 0.30 - 39 x 10-6.
Weaknesses andstrengths ofthe -y-model arediscussedin
Table 3.
Human Dose ofNitro-PAHs
The basis forthe risk calculations is the human lifetime
doseofnitro-PAHs.Basedonliteraturedata,anestimated
lifetime doserangehasbeencalculated,whichisdiscussed
in detail in M6ller et al. (67). The combined risk range is
0.15-49 x 10-6. In the dose calculations, food has been
considered tobezerointermsofnitro-PAH dose, although
this is not the case; food can even be the predominate
source ofnitro-PAHs (16,17). CitieslikeBerlin and Beijing
represent the upper risk range, and cities like Tokyo and
Kawasaki represent the lower risk range. High traffic
intensity, a lot of diesel vehicles, and coal as source of
energyleadtodosesthatposeahighrisk.Somecomments
on the dose are shown in Table 4. In Tables 5 and 6, NF
analyses in urban air and particle extracts are shown. In
Table 7 the factors that could increase or decrease the
calculated riskfornitro-PAHs are discussed. Although no
definite risk limit has been set, a risk of 1 x 10-6 is in
general is considered to be the limit for an unacceptable
risk.Thatrisklimitcouldbeexeededbyafactorofupto50
times in the case ofnitro-PAHs.
Table 3. Weaknesses and strengths ofthe y model.
Weaknesses
Are foci generated from chemicals and y-irradiation in the same
manner?
Recent human risk data on y-irradiation indicate that the risk is
underestimated.
Strengths
Well-knownriskdataonhumans afterexposureto-y-irradiation exists.
Conversion ofgenotoxic lesions to radiation-equivalents.
The y-model is an in vivo model.
Table 4. Weaknesses and strengths regarding current knowledge
on the human exposure to nitro-PAHs.
Weaknesses
Are the literature data on nitro-PAH levels representative?
Sampling temperatures are not given (might influence distribution
gas/particle phase).
Limited information available on the food levels ofnitro-PAHs. Could
be a major source ofnitro-PAHs.
Can plants (for food consumption) along roads absorb and metabolize
nitro-PAHs?
What is the relationship between oral and inhaled dose?
Arethepotentdirect-actingmutagens,theOH-NFs,alsocarcinogens?
Strengths
A large number ofanalyses on urban air.
2-Nitrofluorene seems to be a good model for nitro-PAHs in terms of
dose.
Anequal distributionofnitro-PAHs intheurbanenvironmentdueto a
very large number ofsources.
Abbreviations: nitro-PAHs, nitrated polycyclic aromatic hydrocar-
bons;OH-NF,
Table 5. Quantitation of2-nitrofluorene (NF)
in different environments.
Environment NF, pg/m3 Comment Reference
Tokyoa 24 Winter, residential area (79)
50 Summer, residential area (79)
Kawasakia 71 Autumn, industrial area (79)
Beijingb 190 Residential area, close to road (79)
290 Residential area, close to road (79)
36 Background level (79)
79 Background level (79)
700 Maximum level (79)
Berlinc 1780 n=8 (14)
1510 n=11, over a year (14)
1880 Energy production dominates (80)
1540 Traffic dominates (80)
Japan 1.5 ,ug/kg River sediment (15)
Kerosene heater 568 ng/m3 In the exhaust (10)
19.8 ng/m3 Close to kerosene heater (10)
aBig cities, relatively few vehicles, catalytic cleaning devices, main
traffic flow by underground, and cities located on the coast.
bBig city, very few vehicles, diesel vehicles, no catalytic cleaning of
vehicle emissions, and extensive heating/cooking with coal.
'Big city, many vehicles, typical western-type city, although former
East Berlin has coal as a fuel for heating, which might influence the air
quality in formerWest Berlin where the analyses have been performed.
Table 6. Quantitative data on 2-nitrofluorene (NF)
in vehicle emissions.
Source NF Level Reference
Diesel exhaust, bus 0.13-1.5 ,ug/km (50)
HDD, 100% load, moderate speed 0.63 ,ug/g (soot) (49)
HDD, 75% load, high speed 8.8 ,g/g (49)
Diesel muffler 52.2 ,ug/g (9)
SRM 1650a 15 ,ug/g (49)
HDD, idle 84 ,ug/g (51)
HDD, zero-load, high speed 62 ,ug/g (51)
HDD, full-load, high speed 1.9 Rg/g (51)
LDD, gas phase 90 ,ug/mile (34)
LDD, particle phase 97 ,ug/mile (34)
Gasoline muffler 0.16 ,ug/g (9)
Abbreviations: HDD and LDD, heavy and light duty diesels, respec-
tively.
aThe National Bureau of Standards Reference Diesel Particulate,
USA.
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Table 7. Summary offactors that can increase or decrease
the risk ofnitro-PAHs.
Increase risk
Synergism with other air pollutants occurring in vehicle emissions,
urban air, or in cigarette smoke (nitro-PAHs always occur together
with PAHs).
Nitro-PAH emmission from kerosene heaters (10).
Certain combustions may generate more nitro-PAHs than vehicles
[airplanes and ships (51,74)].
Cigarette smoke might be an unknown source for nitro-PAHs.
Water-phase reactions (PAH + nitrite) could be an additional source
for nitro-PAHs (20,21).
Cooking could be a predominate source ofnitro-PAHs ifthe Japanese
data on chicken are generally applicable (17).
Nitro-PAHs can act as tumor promoters (44) and/or affect tumor
progression.
Exposure to nitro-PAHs could lead to an increased risk of miscar-
riages and malformed offspring because metabolites of 2-nitro-
fluorene (NF) can cause malformation in laboratory animals (82).
Certain other substances can function as co-carcinogens with nitro-
PAHs: one example is benzo(a)pyrene (BaP) (83).
Compared to other nitro-PAHs, NF, which was the base for calcula-
tions, has a low bacterial mutagenicity.
Contamination oftheenvironment ofnitro-PAHsmightbe an addition
to the lifetime dose (15).
If particles are very small (<1.5 ,um), they contain more nitro-PAHs
(84).
Certain risk behaviors (being a child and breathing closer to the
sources ofemissions for instance) are not included.
Certain risk situations are not included (indoor exposure of diesel
exhaust in garages, mines, ferries, etc.).
Certain occupational risk behavior is not included such as cutaneous
exposure ofsoot (workshops, chimney sweeps, etc.).
Metabolism ofother nitro-PAHs mightbe moreimportant than NF in
terms ofgenotoxicity.
Metabolism without intestinal microflora (oxidative pathway) leads to
the formation of more genotoxic metabolites than 2-acetyl-
aminofluorene (AAF) (37-39).
Local sourcesinthecountryside couldgiverisetorelativelyhighlevels
ofnitro-PAHs (diesel tractors, for instance).
The risk calculations performed on the victims from Hiroshima and
Nagasaki, which is the basis for the rad equivalent calculation, can
be underestimated (81).
If nitro-PAHs reacts with cell components other than DNA, it is
possible that other toxic reactions might occur (i.e., reactions with
proteins).
Decrease risk
Measured levelsofNFinBerlinmightnotberepresentative ofcitiesin
general (ithasbeen assumed inthe calculation thaturbanlevels can
be as lowas 10% ofthe Berlin concentration, which is one reason for
the width ofthe risk range).
If NF is not a good model for nitro-PAHs in general in terms of
biological effects.
Theincreased useofcatalytic cleaning devices, althoughthisis notthe
case for diesel vehicles for the moment (which is so far the main
known source for nitro-PAHs).
Ifanimal models are not relevant to human risk.
Metabolism ofother nitro-PAHs islessimportantthan NFinterms of
genotoxic risk.
Ifmetabolism ofNF via the oxidative pathway leads to less genotoxic
metabolites than AAF.
If-y-generated foci are different from chemically induced foci.
Ifantagonismbetween NF andotherxenobioticsreducethepromotive
response.
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